Indian Infotech (509051)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Trades at a P/B of 0.97, slightly below book value of ₹1.53 per share
• Piotroski F-Score of 5/9 suggests moderate financial health, not acute distress
• Latest quarter sales of ₹6 Cr indicate some underlying activity in the investment book
• Reported annual profit growth of 90.88%, though from a low base, shows improvement versus the prior year

Concerns

• Latest quarter net loss of ₹1 Cr and ROE of just 0.77% show weak earnings power
• Negative ROCE of -2.49% means capital employed is not generating operating returns
• No dividend, so minority shareholders receive no income while waiting
• Missing promoter holding and debt/equity data reduce transparency; P/E of 0.00 makes earnings-based valuation unreliable

AI Analysis

Indian Infotech describes itself as an investment company, so my first question is simple: what am I actually buying? The stock trades at ₹1.48, slightly below its stated book value of ₹1.53, giving a P/B of 0.97. That means I can buy a rupee of equity for 97 paise. In a pure asset play, that can be attractive. But in an investment company, the book value is only as trustworthy as the underlying assets and the people managing them. With promoter holding not disclosed and debt/equity not available, I cannot perform the fundamental verification Graham demanded. The operating economics are poor. ROE is just 0.77%, so the equity is generating almost no return. ROCE is negative at -2.49%, and the latest quarter produced a net loss of ₹1 Cr on sales of ₹6 Cr. Sales declined 4.11%. This is not a business with pricing power or a moat; it is a repository of assets earning a negligible return. The reported 90.88% profit growth looks impressive, but from a tiny or depressed base it is meaningless, and a P/E of 0.00 tells me the earnings figure cannot anchor a valuation. There is no dividend, so I receive nothing while waiting. Piotroski F-score of 5/9 suggests moderate health, but no edge. At the 52-week high of ₹1.48, the market has already re-rated this name. I would only consider Indian Infotech as a possible asset play, and only after deep due diligence on its portfolio, related-party transactions, and capital allocation. Otherwise, a slight discount to book is not a margin of safety; it is a value trap.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer